Experiment 330041

Worktypes

PHARMACEUTICAL FORMULATION OFEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPATENT DESCRIBED

Compounds isolated

AMYGDALINVITAMIN B-1

Details

PropertyValue
OrganismEmpty organism
CitationANON:. (1975). PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT.. ()
Amount utilized
Compound isolated
Number1